Close Menu

NEW YORK – FindGene Clinical Laboratories of China said last week that the country's National Medical Products Administration (NMPA) has approved its noninvasive prenatal screening test kit for in vitro diagnostic use.

The sequencing-based test screens for fetal trisomies 21, 18, and 13 using cell-free DNA from maternal blood. It relies on reversible terminator technology optimized by FindGene, which the company said provides "unprecedented accuracy."

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

IBM security researchers warn of a phishing campaign targeted at organizations involved in the distribution of SARS-CoV-2 vaccines, the Verge reports.

The Illinois police have cut the number of DNA tests waiting to be run in about half, CBS Chicago reports.

A researcher accused of smuggling research materials out of the US has pleaded guilty to making false statements, according to the Associated Press.

In Science this week: gene expression signature linked to nonalcoholic fatty liver disease progression, and more.